Home › Funds › BRAIDWELL LP › KRYS

BRAIDWELL LP position in KRYS

KRYSTAL BIOTECH INC · Health Care

BRAIDWELL LP reported holding 128,975 shares of KRYS (KRYSTAL BIOTECH INC) in its Q2 2026 13F filing — a position valued at US$47.9M, representing 1.89% of its reported portfolio and ranking #15 among its reported holdings. BRAIDWELL LP has disclosed KRYS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)128.97K sh
Reported value held$47.94M
Portfolio Weight1.89%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BRAIDWELL LP's KRYS position evolved

BRAIDWELL LP first disclosed a stake in KRYS in Q3 2023 at 77,497 shares (US$9.0M). The position peaked in Q2 2025 at 727,811 shares, worth US$100.0M. Across 12 filings, BRAIDWELL LP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 128,975 shares valued at US$47.9M — a reduction of -53,450 shares quarter over quarter.. Notable position changes include a 153% increase in Q4 2023 (shares rose 43% over the following quarter), a 100% increase in Q1 2025 (shares fell 24% over the following quarter), a 82% increase in Q2 2025 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 77.50K $8.99M New
Q4 2023 196.20K $24.34M Add
Q1 2024 177.09K $31.51M Reduce
Q2 2024 107.18K $19.68M Reduce
Q3 2024 168.69K $30.71M Add
Q4 2024 200.50K $31.41M Add
Q1 2025 400.74K $72.25M Add
Q2 2025 727.81K $100.04M Add
Q3 2025 520.40K $91.87M Reduce
Q4 2025 202.10K $49.83M Reduce
Q1 2026 182.43K $47.12M Reduce
Q2 2026 128.97K $47.94M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KRYS and 13F data

KRYS (KRYSTAL BIOTECH INC) is a Health Care company. 48 other funds we track also report a position in KRYS — the largest reported positions include Avoro Capital Advisors LLC (US$1.07B), Soleus Capital Management, L.P. (US$349.1M), Hood River Capital Management LLC (US$246.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KRYS

All KRYS fund holders →

FAQ

How long has BRAIDWELL LP held KRYS?

BRAIDWELL LP has disclosed KRYS holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is BRAIDWELL LP's current position in KRYS?

As of Q2 2026, BRAIDWELL LP holds 128.97K shares of KRYS (KRYSTAL BIOTECH INC), valued at $47.94M, representing 1.89% of its reported portfolio and ranking #15.

Has BRAIDWELL LP been buying or selling KRYS?

In the latest 13F filing (Q2 2026), BRAIDWELL LP reduced its position in KRYS. The position peaked in Q2 2025 at 727.81K shares.

Which other funds hold KRYS?

Other major institutional holders of KRYS include Avoro Capital Advisors LLC, Soleus Capital Management, L.P., Hood River Capital Management LLC, among 48 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.